Skip Navigation


Nucleic Acids Research Advance Access originally published online on August 21, 2008
Nucleic Acids Research 2008 36(17):5462-5471; doi:10.1093/nar/gkn532
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (3146K) Freely available
Right arrow Screen PDF (450K) Freely available
Right arrowOA All Versions of this Article:
36/17/5462    most recent
gkn532v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Maucksch, C.
Right arrow Articles by Rudolph, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maucksch, C.
Right arrow Articles by Rudolph, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2008, Vol. 36, No. 17 5462-5471
© 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Nucleic Acid Enzymes

Cell type differences in activity of the Streptomyces bacteriophage {phi}C31 integrase

Christof Maucksch1,2, Manish Kumar Aneja1, Elisabeth Hennen1, Alexander Bohla1, Florian Hoffmann1, Markus Elfinger1,2, Joseph Rosenecker1 and Carsten Rudolph1,2,*

1Department of Pediatrics, Ludwig-Maximilians-University, 80337 Munich and 2Free University of Berlin, Department of Pharmacy, 14166 Berlin, Germany

*To whom correspondence should be addressed. Tel: +49 89 5160 7711; Fax: +49 89 5160 7846; Email: carsten.rudolph{at}med.uni-muenchen.de

Received June 30, 2008. Revised July 31, 2008. Accepted August 1, 2008.

Genomic integration by the Streptomyces bacteriophage {phi}C31 integrase is a promising tool for non-viral gene therapy of various genetic disorders. We investigated the {phi}C31 integrase recombination activity in T cell derived cell lines, primary T lymphocytes and CD34+ haematopoietic stem cells in comparison to mesenchymal stem cells and cell lines derived from lung-, liver- and cervix-tissue. In T cell lines, enhanced long-term expression above control was observed only with high amounts of integrase mRNA. Transfections of {phi}C31 integrase plasmids were not capable of mediating enhanced long-term transgene expression in T cell lines. In contrast, moderate to high efficiency could be detected in human mesenchymal stem cells, human lung, liver and cervix carcinoma cell lines. Up to 100-fold higher levels of recombination product was found in {phi}C31 integrase transfected A549 lung than Jurkat T cells. When the {phi}C31 integrase activity was normalized to the intracellular integrase mRNA levels, a 16-fold difference was found. As one possible inhibitor of the {phi}C31 integrase, we found 3- to 5-fold higher DAXX levels in Jurkat than in A549 cells, which could in addition to other yet unknown factors explain the observed discrepancy of {phi}C31 integrase activity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.